Drug intelligence / Profile preview

Guzheng Wan

Development stage: Unknown
Lead developer: Handan Pharmaceutical
Administration: Oral

Overview

Guzheng Wan is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Handan Pharmaceutical. It is primarily indicated for the treatment of abdominal distension (ascites) and edema, conditions frequently associated with liver cirrhosis, chronic nephritis, and heart failure. The formulation typically includes botanical ingredients such as *Artemisia keiskeana* (Anluozi), *Gleditsia sinensis* (Zaojiao), and *Euphorbia kansui* (Gansui). In TCM theory, it is classified as a formula that expels water and reduces swelling (逐水消肿). Pharmacologically, it acts as a potent diuretic and purgative, promoting the excretion of excess fluid through the renal and gastrointestinal systems to alleviate pressure in the abdominal cavity.

Brand names: Guzheng Wan
Other names: 臌症丸Guzheng Pills

Beyond the preview

Go deeper on Guzheng Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guzheng Wan.

Explore the full profile